ADJUVANT IMMUNOTHERAPY WITH BCG IN STAGE-II MALIGNANT-MELANOMA

被引：5

作者：

BYRNE, MJ

VANHAZEL, G

REYNOLDS, PM

LEMISH, WM

HOLMAN, CDJ

机构：

[1] MAYO CLIN & MAYO FDN,DIV DEV ONCOL RES,ROCHESTER,MN 55901

[2] UNIV WESTERN AUSTRALIA,DEPT MED,NH & MRC RES UNIT EPIDEMIOL & PREVENT MED,NEDLANDS,WA 6009,AUSTRALIA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 1983年 / 23卷 / 02期

关键词：

D O I：

10.1002/jso.2930230215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：114 / 116

页数：3

共 7 条

[1] A MULTIFACTORIAL ANALYSIS OF MELANOMA .3. PROGNOSTIC FACTORS IN MELANOMA PATIENTS WITH LYMPH-NODE METASTASES (STAGE-II) [J].

BALCH, CM ;

SOONG, SJ ;

MURAD, TM ;

INGALLS, AL ;

MADDOX, WA .

ANNALS OF SURGERY, 1981, 193 (03) :377-388

[2]

CUNNINGHAM T, 1979, ADJUVANT THERAPY CAN, V2, P507

[3] ADJUVANT IMMUNOTHERAPY WITH BCG IN TREATMENT OF REGIONAL-LYMPH-NODE METASTASES FROM MALIGNANT-MELANOMA [J].

EILBER, FR ;

MORTON, DL ;

HOLMES, EC ;

SPARKS, FC ;

RAMMING, KP .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (05) :237-240

[4]

GUTTERMAN JU, 1973, LANCET, V1, P1208

[5]

MORTON DL, 1980, 2ND INT C IMM CANC B

[6] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39

[7] IMMUNOLOGICAL STATUS MAY PREDICT CLINICAL OUTCOME IN BCG TREATED MELANOMA [J].

REYNOLDS, PM ;

GRIMSLEY, G ;

DAWKINS, RL ;

BYRNE, MJ ;

ZILKO, PJ .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (01) :39-43

← 1 →